Current readings: sublobar resection for non-small-cell lung cancer

Area of Science:

• Thoracic Surgery
• Oncology
• Pulmonary Medicine

Background:

• The 1995 Lung Cancer Study Group consensus recommended lobectomy for stage I non-small-cell lung cancer (NSCLC) to minimize recurrence risk.
• Advances in imaging and molecular biology have identified smaller, more indolent NSCLC tumors in recent patient cohorts.
• Single-institution trials suggest sublobar resection offers comparable survival and recurrence rates to lobectomy in well-selected patients, with a better risk profile.

Purpose of the Study:

• To review current literature on sublobar resections for stage I NSCLC.
• To compare sublobar resections with nonoperative ablative therapies for medically unfit patients.
• To identify patient subsets within the standard-risk population for whom sublobar resection yields equivalent outcomes to lobectomy.

Main Methods:

• Literature review of recent studies on sublobar resections for stage I NSCLC.
• Analysis of comparative data between sublobar resection and lobectomy.
• Evaluation of outcomes for medically unfit patients undergoing sublobar resection or ablative therapies.
• Identification of criteria for selecting standard-risk patients for sublobar resection.

Main Results:

• Sublobar resection shows promise as an alternative to lobectomy for specific stage I NSCLC cases.
• Evidence suggests comparable survival and recurrence rates between sublobar resection and lobectomy in selected patients.
• The review addresses the efficacy of sublobar resection versus nonoperative options for medically compromised individuals.
• Key factors for identifying suitable candidates for sublobar resection in the standard-risk population are explored.

Conclusions:

• Sublobar resection is an increasingly viable option for stage I NSCLC, particularly in selected patient groups.
• Further research is needed to refine patient selection criteria for sublobar resection in both medically unfit and standard-risk populations.
• The findings challenge the traditional reliance on lobectomy for all stage I NSCLC, advocating for personalized treatment approaches.